Lisa is a stock analyst with nearly 25 years of investment research experience. She earned a MBA in Finance from the University of Chicago in 1987 and began her career in investment research that same year as part of the equity research team at Kemper Financial Services. In 1989, Lisa joined the Financial Relations Board, a large investor relations consulting firm, rising to the position of director of financial analysis.
During her tenure with FRB, Lisa was a consultant to Boston Market, MGI Pharma, Devon Energy and other Fortune 1000 companies. In 2000, Lisa left to become director of investor Relations for a NYSE-listed REIT, serving in that position until the REIT was acquired. Since then, Lisa has worked as a stock analyst for independent research firms, investment newsletters and financial websites.
Analyst Articles
International dividend stocks are a great way to add diversification to a portfolio, especially since it’s easier to find faster growth outside the United States. Owning foreign stocks could become even more compelling in… Read More
The presidential election is over, but another day of reckoning approaches. A “fiscal cliff” consisting of major tax increases and spending cuts is quickly approaching. And with it, a broad swath of investments ranging from stocks and… Read More
Dividend-growth stocks can do wonders for an investor’s portfolio over time. The power of compounding can turn today’s ho-hum yield into a stellar return if the growth rate of the dividend is high. … Read More
For an income investor, peace of mind comes from being able to offset monthly expenses with dividend income. This can be easily accomplished by owning monthly dividend stocks. There are many advantages to owning stocks that pay out monthly, rather than quarterly… Read More
Too often, income investors are forced to choose between dividend yields and growth. Fast-growing companies rarely pay dividends, since they need their cash for business expansion. Those with generous yields are usually either mature, out-of-favor companies or slow-growth utilities and telecoms. For… Read More
Income investors can find attractive high-yields in the pharmaceutical sector right now. Many major drug makers, including familiar names like Merck (NYSE: MRK), Johnson & Johnson (NYSE: JNJ) and Bristol Myers Squibb (NYSE: BMY), are yielding close to 4% or better. But with so many stocks in this segment, deciding… Read More
About 10 years ago, an investor could have purchased 100 shares of Apple (Nasdaq: AAPL) for $1,200. Today, those same shares are worth an extraordinary $675,000. Not counting dividends, that’s a better than 56-fold return on your investment in just 10 years. Read More
Whatever your political views, there’s no dispute that Mitt Romney has been extremely successful as an investor. At Bain Capital, Romney used the power of private equity to earn huge returns by investing in underperforming companies, turning these businesses around and sharing in the profits. Investing like Romney requires millions… Read More
The summer of 2012 will long be remembered for the worst drought in more than 50 years and conceivably the worst since the Dust Bowl. More than 80% of U.S. grain crops have been affected by this year’s drought and the economic effect will be felt next year with harvests… Read More
If you’re an income investor who strives for stable, high-yielding assets, then you should be looking at master limited partnerships (MLPs). Particularly right now, MLPs can be terrific investments — their yields are exceptional, averaging nearly 7% and well above the average yields for utility stocks (about 4%),… Read More
